Merck KGaA, Darmstadt, Germany, Opens Application Phase for Next Accelerator

05 JUN 2019 | DARMSTADT, GERMANY Start-ups can apply for programs at company headquarters in Darmstadt or in China Focus is on four fields: biosensing & interfaces, liquid biopsy technologies, clean meat, and artificial intelligence (AI)-enabled health solutions Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that that it has opened the next... Read more

Agilent Technologies Announces Webcasts for Investment Community

Agilent Technologies Announces Webcasts for Investment Community SANTA CLARA, Calif., June 4, 2019 Agilent Technologies Inc. (NYSE: A) today announced the following upcoming webcasts for the investment community: Jefferies 2019 Healthcare Conference Thursday, June 6, at 11:00 a.m. (ET)Grand Hyatt, New YorkBob McMahon, Agilent chief financial officer Goldman Sachs 40th Annual Global Healthcare ConferenceTuesday, June... Read more

Illumina Introduces Expanded Version of VeriSeq™ NIPT Solution, Offering More Comprehensive Detection of Rare Chromosomal Conditions

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced the launch of VeriSeq™ NIPT Solution v2, a CE-IVD, next-generation sequencing (NGS)-based approach to noninvasive prenatal testing (NIPT). The automated comprehensive solution allows laboratories to screen for a broader range of chromosomal and sub-chromosomal conditions associated with birth defects and adverse pregnancy outcomes than the standard NIPT... Read more

New Instrument for Automated Antimicrobial Susceptibility Testing Provides Gold Standard-Level Minimum Inhibitory Concentration (MIC) Accuracy1

New Instrument for Automated Antimicrobial Susceptibility Testing Provides Gold Standard-Level Minimum Inhibitory Concentration (MIC) Accuracy1 Instrument utilizes gold standard broth microdilution method to guide more targeted patient therapy and optimize patient outcomes BASINGSTOKE, England. (June 4, 2019) – A new benchtop automated reading and incubation system is now available in Europe for antimicrobial susceptibility testing... Read more

Agilent Survey of Pharma Lab Leaders Uncovers Challenges in Workflow and Laboratory Efficiencies

Agilent Survey of Pharma Lab Leaders Uncovers Challenges in Workflow and Laboratory Efficiencies SANTA CLARA, Calif., June 4, 2019 Agilent Technologies Inc. (NYSE: A) announced today the results of its first Pharma Lab Leaders Survey looking to gather insights from pharmaceutical, biopharmaceutical, and contract research laboratories in seven countries around the world. Respondents included 650... Read more

908 Devices broadens the ZipChip platform, brings new capability to biotherapeutics researchers

BOSTON, June 3, 2019 — 908 Devices, a pioneer of analytical devices for chemical and biomolecular analysis, today announced several advancements to their ZipChip® product line, which build upon its industry-leading biotherapeutic analysis capabilities in multiple critical application areas. These product and application expansions will be showcased at the 67th Annual ASMS Conference being held in... Read more

Analytical Software Solutions Reveal Valuable Data Insights in Real Time

Thermo Scientific software suite delivers enhanced performance, usability and connectivity ATLANTA, June 3, 2019 /PRNewswire/ — ASMS 2019 – New enhancements to a suite of analytical software solutions offer access to data insights with the speed and confidence laboratories require in pharmaceutical, food, environmental, industrial, research, academic, clinical and forensic settings. The latest software aids scientists in... Read more

Thermo Fisher Scientific Extends Industry-leading Mass Spectrometry Portfolio with a New Generation of Intelligence-Driven Instruments and Software

Thermo Fisher Scientific Extends Industry-leading Mass Spectrometry Portfolio with a New Generation of Intelligence-Driven Instruments and Software Innovative solutions integrate new data acquisition, analytical and smart algorithm capabilities ATLANTA, June 3, 2019 /PRNewswire/ — ASMS 2019 — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is accelerating the pace of innovation in the... Read more

Thermo Fisher Scientific's Oncomine Dx Target Test Receives Reimbursement Coverage in Japan

Thermo Fisher Scientific’s Oncomine Dx Target Test Receives Reimbursement Coverage in Japan CARLSBAD, Calif., June 3, 2019 /PRNewswire/ — Thermo Fisher Scientific today announced that its Oncomine Dx Target Test CDx System has received reimbursement coverage from Japan’s Ministry of Health, Labour and Welfare and is now commercially available in that country. The next-generation sequencing (NGS)-based... Read more